Terms: = Liver cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Diagnosis
174 results:
1. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
2. diagnosis and management of immune mediated liver injury from checkpoint inhibitors.
Likhitsup A; Fontana RJ
Curr Opin Gastroenterol; 2024 May; 40(3):164-171. PubMed ID: 38375823
[TBL] [Abstract] [Full Text] [Related]
3. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies.
Reimer P; Vilgrain V; Arnold D; Balli T; Golfieri R; Loffroy R; Mosconi C; Ronot M; Sengel C; Schaefer N; Maleux G; Munneke G; Peynircioglu B; Sangro B; Kaufmann N; Urdaniz M; Pereira H; de Jong N; Helmberger T
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):310-324. PubMed ID: 38321223
[TBL] [Abstract] [Full Text] [Related]
4. Sarcopenia and Neuroendocrine Neoplasms.
Clement D; Brown S; Leerdam MV; Tesselaar M; Ramage J; Srirajaskanthan R
Curr Oncol Rep; 2024 Feb; 26(2):121-128. PubMed ID: 38270848
[TBL] [Abstract] [Full Text] [Related]
5. Hepatic Metastasectomy in Pediatric Patients: An Observational Study.
Fleming AM; Mansfield SA; Jancelewicz T; Gosain A; Eubanks JW; Davidoff AM; Langham MR; Murphy AJ
J Pediatr Surg; 2024 Feb; 59(2):247-253. PubMed ID: 37980196
[TBL] [Abstract] [Full Text] [Related]
6. The Broad Spectrum of Paediatric Pancreatic Disease: A Single-center 26-years Retrospective Review.
Alnagar A; Khamag O; Sharif K; Mirza DF; Ong EGP
J Pediatr Surg; 2024 Feb; 59(2):261-267. PubMed ID: 37957099
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes of Primary Tumor Excision do not Differ from Non-Resection Methods in Pediatric Mesenchymal Hamartoma of the liver: A Rapid Systematic Review.
Bauzon J; Froehlich M; Dadon N; Morris D; Chang S
J Pediatr Surg; 2023 Dec; 58(12):2356-2361. PubMed ID: 37775408
[TBL] [Abstract] [Full Text] [Related]
8. Screening, diagnosis, and Staging of Non-Alcoholic Fatty liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice.
Ilagan-Ying YC; Banini BA; Do A; Lam R; Lim JK
Curr Gastroenterol Rep; 2023 Oct; 25(10):213-224. PubMed ID: 37768417
[TBL] [Abstract] [Full Text] [Related]
9. Challenges and physiological implications of sarcopenia in children and youth in health and disease.
Mager DR; Hager A; Gilmour S
Curr Opin Clin Nutr Metab Care; 2023 Nov; 26(6):528-533. PubMed ID: 37750867
[TBL] [Abstract] [Full Text] [Related]
10. A rare primary hepatic neuroendocrine tumour with laparoscopic resection: a case report.
Alghamdi HM
J Med Case Rep; 2023 Jun; 17(1):296. PubMed ID: 37386646
[TBL] [Abstract] [Full Text] [Related]
11. Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma.
Whitlock RS; Portuondo JI; Espinoza AF; Ortega R; Galván NTN; Leung DH; Lopez-Terrada D; Masand P; Nguyen HN; Patel KA; Goss JA; Heczey AM; Vasudevan SA
J Pediatr Surg; 2023 Sep; 58(9):1715-1726. PubMed ID: 37244849
[TBL] [Abstract] [Full Text] [Related]
12. Small bowel neuroendocrine tumours - casting the net wide.
Chetcuti Zammit S; Sidhu R
Curr Opin Gastroenterol; 2023 May; 39(3):200-210. PubMed ID: 37144538
[TBL] [Abstract] [Full Text] [Related]
13. Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question.
Dijke K; Kuhlmann KFD; Levy S; Tesselaar MET
Curr Oncol Rep; 2023 Jun; 25(6):679-688. PubMed ID: 37004701
[TBL] [Abstract] [Full Text] [Related]
14. MRI of Peliosis Hepatis: A Case Series Presentation With a 2022 Systematic Literature Update.
Calistri L; Nardi C; Rastrelli V; Maraghelli D; Grazioli L; Messerini L; Colagrande S
J Magn Reson Imaging; 2023 Nov; 58(5):1386-1405. PubMed ID: 36988385
[TBL] [Abstract] [Full Text] [Related]
15. Histological evaluation in biliary diseases.
Saffioti F; Vieira Motta R; Quaglia A
Curr Opin Gastroenterol; 2023 Mar; 39(2):75-82. PubMed ID: 36821454
[TBL] [Abstract] [Full Text] [Related]
16. Enhanced glypican-3-targeted identification of hepatocellular carcinoma with liver fibrosis by pre-degrading excess fibrotic collagen.
Zhuo J; Wang Y; Hui H; Li C; Yang J; Zhang P; Fang C; Tian J
Acta Biomater; 2023 Mar; 158():435-448. PubMed ID: 36603729
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma.
Buyukkor M; Tay F; Karacin C; Duran AO
J Coll Physicians Surg Pak; 2023 Jan; 33(1):32-36. PubMed ID: 36597232
[TBL] [Abstract] [Full Text] [Related]
18. liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?
Kodali S; Saharia A; Ghobrial RM
Curr Opin Organ Transplant; 2022 Aug; 27(4):320-328. PubMed ID: 36354258
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract] [Full Text] [Related]
20. Visualization Score of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging: The Effect on the Diagnostic Accuracy for Hepatocellular Carcinoma.
Heo S; Choi SH; Hong S; Kim DW
J Magn Reson Imaging; 2023 Mar; 57(3):941-949. PubMed ID: 35849038
[TBL] [Abstract] [Full Text] [Related]
[Next]
